College of Medicine – Tucson
When
Location
Target Audience
Overview
The 2nd Annual Hepato-Pancreato-Biliary (HPB) Symposium will take place on September 13, 2025 at the Westin La Paloma, 3800 E Sunrise Dr, Tucson, AZ 85718. The conference will provide education on the care of complex Hepato-Pancreato-Biliary (HPB, including pancreas, liver, and bile duct) malignancies, with a focus on cutting-edge technology, oncologic advances, and multidisciplinary management of these complex problems. Leading experts in the fields of HPB surgery, medical oncology, surgical oncology, interventional gastroenterology, and interventional radiology will discuss the advances in pancreatic cancer, management and decision-making in pancreatic cystic lesions, and cutting-edge management of colorectal liver metastases. There will be multidisciplinary case discussions included to illustrate decision-making and engage participants across the medical community in Arizona. This conference is a great learning opportunity for general surgeons, medical oncologists, radiation oncologists, gastroenterologists, primary care physicians, colorectal surgeons, and HPB specialists who encounter these problems in their practice.
Registration Fee
Medical Students - $15
Nurses, All Other HCPs - $50
Residents, Fellows - $50
Attendings/Practicing Physicians - $150
Objectives
- Describe the role of, and utilize when appropriate, complete tumor sequencing in identification of targetable mutations in pancreatic cancer to guide management.
- Incorporate knowledge of the evolving role of circulating tumor- DNA (ct-DNA) in prognosis, decisions regarding adjuvant therapy and in detection of early recurrence.
- Employ criteria for vascular resection in pancreatic cancer.
- Identify pancreatic cystic lesions on cross-sectional imaging, and recognize the high-risk stigmata and worrisome features that suggest the presence of cancer in these cysts.
- Describe histotripsy and recognize the potential of abscopal effect.
- Describe indications for evolving techniques in the treatment of metastatic colorectal cancer.
- Employ complex multidisciplinary discussions in patients with metastatic colorectal cancer given rapidly evolving treatment options that offer hope to patients with previously unresectable disease.
Credits
AMA PRA Category 1 Credits™ (7.50 hours), ABS CC (7.50 hours), Non-Physician Attendance (7.50 hours)